cholecalciferol and Nasopharyngeal-Neoplasms

Tumor-induced osteomalacia is a rare paraneoplastic syndrome characterized by hypophosphatemia and inappropriately normal or low 1,25-dihydroxyvitamin D.. Here, we report a 6-year postoperative follow-up of a patient with oncogenic osteomalacia with a distinctive skeletal manifestation. The latter was characterized by an almost linear lytic lesion of a few millimeters with irregular borders, mainly involving the trabecular compartment but extending into cortical shell, located in the middle third of the right fibula. Six years after tumor resection, a sclerotic repair with a complete recovery was observed. Furthermore, we monitored a striking increase in bone mineral density throughout the observation period, reaching a peak of 73% over basal values at lumbar spine after 2 years; at total femur and radius, the peak was 47.5 and 4.6% respectively, after 4 years from tumor resection.. We report for the first time that an osteolytic lesion may be part of the skeletal involvement in tumor-induced osteomalacia.

Topics: Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Cholecalciferol; Combined Modality Therapy; Dietary Supplements; Female; Fibula; Fractures, Stress; Humans; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms, Connective Tissue; Osteomalacia; Paraneoplastic Syndromes; Postoperative Complications; Radiography; Treatment Outcome; Up-Regulation